FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Studer Jacqueline   2. Issuer Name and Ticker or Trading Symbol IDEXX LABORATORIES INC /DE [IDXX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CVP, Gen. Counsel & Secretary (Last) (First) (Middle) ONE IDEXX DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 02/14/2018 (Street) WESTBROOK, ME 04092 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/14/2018   M   346 A $ 0 4,757 (1) D   Common Stock 02/14/2018   M   406 A $ 0 5,163 D   Common Stock 02/14/2018   M   212 A $ 0 5,375 D   Common Stock 02/14/2018   F   298 D $ 178.26 (2) 5,077 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	$ 178.26	02/14/2018		A		8,007		(3)	02/13/2028	Common Stock	8,007	(9)	8,007	D
Incentive Stock Option (right-to-buy)	$ 178.26	02/14/2018		A		560		(4)	02/13/2028	Common Stock	560	(9)	560	D
Restricted Stock Unit	(5)	02/14/2018		A		841		(5)	(5)	Common Stock	841	(9)	6,815	D
Restricted Stock Unit	(6)	02/14/2018		M			346	(6)	(6)	Common Stock	346	(9)	6,469	D
Restricted Stock Unit	(7)	02/14/2018		M			406	(7)	(7)	Common Stock	406	(9)	6,063	D
Restricted Stock Unit	(8)	02/14/2018		M			212	(8)	(8)	Common Stock	212	(9)	5,851	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Studer Jacqueline ONE IDEXX DRIVE WESTBROOK, ME 04092			CVP, Gen. Counsel & Secretary

Signatures

/s/ Lily J. Lu, Attorney-in-Fact for Jacqueline L. Studer		02/16/2018
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes a total of 72 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 29, 2017 and December 29, 2017.
(2)	Closing price of Issuer's common stock on the NASDAQ market on February 14, 2018.
(3)	Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2019.
(4)	Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.
(5)	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019.
(6)	Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.
(7)	Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
(8)	Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018.
(9)	Not applicable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.